Yüklüyor......
Alemtuzumab for multiple sclerosis
BACKGROUND: Multiple sclerosis (MS) is an autoimmune, T‐cell‐dependent, inflammatory, demyelinating disease of the central nervous system, with an unpredictable course. Current MS therapies focus on treating exacerbations, preventing new exacerbations and avoiding the progression of disability. Howe...
Kaydedildi:
| Yayımlandı: | Cochrane Database Syst Rev |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Ltd
2016
|
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486037/ https://ncbi.nlm.nih.gov/pubmed/27082500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011203.pub2 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|